CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT

The aim of the research is to study nosological structure, features of kidney, lung damage, deaths in patients with ANCA – associated vasculitis underwent medical treatment in a multidisciplinary hospital.

Material and methods. Selection and subsequent retrospective analysis of the medical histories of 38 inpatient patients observed in nephrological, rheumatological, pulmonological and surgical thoracic departments for the period from January 2012 to december 2018 were carried out. The disease main clinical symptoms, variants of the X-ray picture, and causes of death were assessed in the patients according to the clinical and laboratory examination.

Results and discussion. The most common diagnosis was eosinophilic granulomatosis with polyangiitis (EGPA) – 16 cases; microscopic polyangiitis was diagnosed in 11 patients, granulomatosis with polyangiitis – in 9 persons. in 2 cases, ANCA-associated vasculitis was diagnosed without specifying the nosological form. The most common symptoms in patients with ANCA-vasculitis were fever, progressive shortness of breath, weakness, artalgia, eosinophilia, which occurred mainly in patients with EGPA. Among analyzed 38 cases, there were 6 men and 32 women. The average age of patients was 50.72 ± 12.6 years. There were 5 deaths and, in 2 cases, the outcome could not be clarified. All deaths occurred during the first year from the disease onset caused by infectious complications or severe manifestations of the main disease.

1. Anderson G., Coles E.T., Crane M., douglasA.C., Gibbs A.R., Geddes d.M., Peel E.T., Wood J.B. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a subcommittee of the British Thoracic Society Research Committee. Q. J. Med. 1992; 83: 427–438.

2. Ando Y., okada F., Matsumoto S., Mori H. Thoracic manifestation of myeloperoxidase antineutrophil cytoplasmic antibody (MPo-ANCA)-related disease. CT findings in 51 patients. J. Comput. Assist. Tomogr. 2004; 28: 710–716. doi: 10.1097/01.rct.0000135280.79012.c7

3. Arulkumaran N., Periselneris N., Gaskin G., Strickland N., ind P.W., Pusey C.d., Salama A.d. interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford). 2011; 50: 2035–2043.

4. Comarmond C., Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun. Rev. 2014; 13: 1121–5. PMid: 25149391. doi: 10.1016/j.autrev.2014.08.017

5. Comarmond C., Crestani B., Tazi A., Hervier B., Adam-Marchand S., Nunes H., Cohen-Aubart F., Wislez M., Cadranel J., Housset B., Lloret-Linares C., Sève P., Pagnoux C., Abad S., Camuset J., Bienvenu B., duruisseaux M., Hachulla E., Arlet J.B., Hamidou M., Mahr A., Resche-Rigon M., Brun A.L., Grenier P., Cacoub P., Saadoun d. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore). 2014; 93: 340–349. doi: 10.1097/01.md.0000460807.23213.65

6. Furuta S., Chaudhry A.N., Hamano Y., Fujimoto S., Nagafuchi H., Makino H., Matsuo S., ozaki S., Endo T., Muso E., ito C., Kusano E., Yamagata M., ikeda K., Kashiwakuma d., iwamoto i., Westman K., Jayne d. Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J. Rheumatol. 2014; 41: 325–333. doi: 10.3899/jrheum.160005

7. Guillevin L., durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., Amouroux J., Casassus P., Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999; 42: 421–430. doi: 10.1002/1529-0131(199904)42:3<421::Aid-ANR5>3.0.Co;2-6

8. Hassan T.M., Hassan A.S., igoe A., Logan M., Gunaratnam C., McElvaney N.G., o’Neill S.J. Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow-up in ANCA-associated vasculitis. BMC Immunol. 2014; 15: 20. doi: 10.1186/1471-2172-15-20

9. Hervier B., Pagnoux C., Agard C., Haroche J., Amoura Z., Guillevin L., Hamidou M.A.; French Vasculitis Study Group. Vasculitis study, pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann. Rheum. Dis. 2009; 68: 404–407. doi: 10.1136/ard.2008.096131

10. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.d., Rottem M., Fauci A.S. Wegener granulomatosis: an analysis of 158 patients. Ann. Intern. Med. 1992; 116: 488–498. doi: 10.7326/0003-4819-116-6-488

11. Holle J.U., Gross W.L. Treatment of ANCAassociated vasculitides (AAV). Autoimmun. Rev. 2013; 12: 483–486.

12. Huang H., Wang Y.X., Jiang C.G., Liu J., Li J., Xu K., Xu Z.J. A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China. BMC Pulm. Med. 2014; 14: 8. doi: 10.1186/1471-2466-14-8

13. Nathan S.d., Albera C., Bradford W.Z., Costabel U., Glaspole i., Glassberg M.K., Kardatzke d.R., daigl M., Kirchgaessler K.U., Ancaster L.H., Lederer d.J., Pereira C.A., Swigris J.J., Valeyre d., Noble P.W. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir. Med. 2017; 5: 33–41. doi: 10.1016/S2213-2600()30326-5

14. Reinhold-Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nolle B. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: longterm outcome in 155 patients. Arthritis Rheum. 2000; 43: 1021–1032.

15. Schirmer J.H., Wright M.N., Vonthein R., Herrmann K., Nölle B., Both M., Henes F.o., Arlt A., Gross W.L., Schinke S., Reinhold-Keller E., Moosig F., Holle J.U. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford). 2016; 55: 71–79. doi: 10.1093/rheumatology/kev286

16. Tomas Chaume L., Martinez Escude A., ortizSantamaria V. Pulmonary fibrosis in patients with positive neutrophil cytoplasmic antibodies vasculitis. Clin. Exp. Rheumatol. 2016; 34 (3, Suppl. 97): S145.

17. Tzelepis G.E., Kokosi M., Tzioufas A., Toya S.P., Boki K.A., Zormpala A., Moutsopoulos H.M. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur. Respir. J. 2010; 36: 116–121. doi: 10.1183/09031936.00110109

18. Yamagata M., ikeda K., Tsushima K., iesato K., Abe M., ito T., Kashiwakuma d., Kagami S., iwamoto i., Nakagomi d., Sugiyama T., Maruyama Y., Furuta S., Jayne d., Uno T., Tatsumi K., Nakajima H. Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients. Arthritis Rheum. 2016; 68: 713–273. doi: 10.1002/art.39475